erythromycin has been researched along with Cystic Fibrosis in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (38.71) | 18.7374 |
1990's | 2 (6.45) | 18.2507 |
2000's | 11 (35.48) | 29.6817 |
2010's | 6 (19.35) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Besier, S; Brade, V; Kahl, BC; Kraiczy, P; Wichelhaus, TA; Zander, J | 1 |
Eshaghurshan, CS; Grinwis, ME; Parkins, MD; Rabin, HR; Sibley, CD; Surette, MG | 1 |
Adir, Y; Lavon, O; Schneer, S; Shteinberg, M | 1 |
Bruce, KD; Cuthbertson, L; Martin, ML; Rogers, GB; Serisier, DJ; Thomson, SK; van der Gast, CJ | 1 |
Alffenaar, JW; Buchard, A; Dalbøge, CS; Dalhoff, K; Duno, M; Høiby, N; Jensen, AG; Johansen, HK; Jürgens, G; Nielsen, XC; Pressler, T; Uges, DR | 1 |
Hofmann, T; Scheuch, G; Siekmeier, R | 1 |
Antony, VB; Collins, DP; Drane, WE; Nichols, W; Olson, EL; Tonelli, AR | 1 |
Coulter, WA; Elborn, JS; Goldsmith, CE; Maeda, Y; Mason, C; Matsuda, M; McCalmont, M; Millar, BC; Moore, JE; Rendall, J; Tazumi, A | 1 |
Alihodžić, S; Bencetić Mihaljević, V; Bosnar, M; Bošnjak, B; Brajša, K; Culić, O; Eraković Haber, V; Glojnarić, I; Hrvačić, B; Jelić, D; Kapić, S; Koštrun, S; Kragol, G; Marušić Ištuk, Z; Padovan, J; Spaventi, R; Tavčar, B; Verbanac, D; Vujasinović, I | 1 |
Elphick, H; Evans, GS; Everard, ML; Jones, A; Pettitt, E | 1 |
Leclercq, R; Malbruny, B; Picard, B; Prunier, AL; Tandé, D | 1 |
Schöni, MH | 1 |
LAWSON, D; SAGGERS, BA | 2 |
STAMM, SJ; TIDWELL, RA | 1 |
MANLAPAS, FC; OPALKA, E; PATTERSON, P; SOIKE, K; STEIN, AA | 1 |
Azuma, A | 1 |
Fecik, RA; Nguyen, PL; Venkatraman, L | 1 |
Bukowskyj, M; Munt, PW; Nakatsu, K | 1 |
Primavesi, CA; Witte, A | 1 |
Kitade, M; Moritaka, T; Nakanishi, N; Ueda, N | 1 |
Brennan, S; Cooper, D; Sly, PD | 1 |
Cole, PJ; Shibuya, Y; Wills, PJ | 1 |
Gaylor, AS; Reilly, JC | 1 |
Tanimoto, H | 1 |
Blackhall, MI; McKay, G; Rawal, BD | 1 |
Denning, CR; Kutscher, AH; Ragosta, JM; Zegarelli, EV | 1 |
Ahl, LA; Fisher, MW; Muschel, LH | 1 |
Lacey, RW; Lewis, E; Rosdahl, VT | 1 |
Valman, HB | 1 |
Evans, KE; Valman, HB | 1 |
7 review(s) available for erythromycin and Cystic Fibrosis
Article | Year |
---|---|
[LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Erythromycin; Humans; Lung Diseases; Macrolides | 2016 |
Inhalation of macrolides: a novel approach to treatment of pulmonary infections.
Topics: Administration, Inhalation; Aerosols; Animals; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; Cystic Fibrosis; Erythromycin; Humans; Ketolides; Lung; Macrolides; Pulmonary Disease, Chronic Obstructive; Rats | 2015 |
Macrolide antibiotic therapy in patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Cystic Fibrosis; Erythromycin; Humans; Randomized Controlled Trials as Topic | 2003 |
[Therapeutic efficacy of macrolide anti-infective agents and other pharmacological actions].
Topics: Anti-Infective Agents; Asthma; Azithromycin; Bronchiolitis; Chronic Disease; Clinical Trials as Topic; Cystic Fibrosis; Erythromycin; Gene Expression Regulation, Bacterial; Humans; Macrolides; Mucins; Neutrophils; Pancreatic Elastase; Pseudomonas aeruginosa; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; Sinusitis; Structure-Activity Relationship | 2005 |
Approaches to the synthesis of immunolides: selective immunomodulatory macrolides for cystic fibrosis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Combinatorial Chemistry Techniques; Cystic Fibrosis; Drug Design; Erythromycin; Humans; Immunologic Factors; Inflammation; Macrolides | 2005 |
Theophylline reassessed.
Topics: Acidosis; Aging; Allopurinol; Animals; Anti-Bacterial Agents; Breast Feeding; Bronchodilator Agents; Caffeine; Contraceptives, Oral; Cooking; Cystic Fibrosis; Drug Interactions; Erythromycin; Female; Heart Diseases; Histamine H2 Antagonists; Humans; Hypoxia; Infections; Kinetics; Liver Diseases; Lung Diseases, Obstructive; Maternal-Fetal Exchange; Phenobarbital; Phenytoin; Pregnancy; Respiration Disorders; Sleep; Smoking; Theophylline | 1984 |
Therapy with macrolides in patients with cystic fibrosis.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Cystic Fibrosis; Erythromycin; Humans; Inflammation; Molecular Structure; Pseudomonas aeruginosa | 2002 |
2 trial(s) available for erythromycin and Cystic Fibrosis
Article | Year |
---|---|
Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bronchi; Bronchiectasis; Bronchoalveolar Lavage Fluid; Colony Count, Microbial; Cross-Sectional Studies; Cystic Fibrosis; Disease Progression; DNA, Bacterial; Dose-Response Relationship, Drug; Double-Blind Method; Erythromycin; Female; Forced Expiratory Volume; Humans; Male; Metagenome; Middle Aged | 2013 |
Directed neutrophil migration to IL-8 is increased in cystic fibrosis: a study of the effect of erythromycin.
Topics: Adolescent; Anti-Bacterial Agents; Chemotaxis, Leukocyte; Child; Cystic Fibrosis; Erythromycin; Female; Humans; Interleukin-8; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils | 2001 |
22 other study(ies) available for erythromycin and Cystic Fibrosis
Article | Year |
---|---|
The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cystic Fibrosis; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Phenotype; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Thymidine | 2008 |
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
Topics: Anti-Bacterial Agents; Azithromycin; Clindamycin; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Macrolides; Streptococcus milleri Group; Tetracycline | 2010 |
Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Biotransformation; Breath Tests; Chromatography, Liquid; Clarithromycin; Cystic Fibrosis; Cytochrome P-450 CYP3A; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Genetic Association Studies; Humans; Male; Polymorphism, Single Nucleotide; Prospective Studies; Risk Assessment; Tandem Mass Spectrometry; Treatment Failure | 2014 |
Erythromycin improves gastric emptying half-time in adult cystic fibrosis patients with gastroparesis.
Topics: Adult; Cystic Fibrosis; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Gastroparesis; Humans; Male; Radionuclide Imaging; Retrospective Studies; Technetium; Treatment Outcome; Young Adult | 2009 |
Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Cystic Fibrosis; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Streptococcal Infections; Streptococcus | 2009 |
N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Bronchiolitis; Bronchoalveolar Lavage Fluid; Cell Line; Clarithromycin; Cystic Fibrosis; Drug Interactions; Drug Resistance, Bacterial; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Interleukin-6; Lipopolysaccharides; Lung; Macrolides; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moraxella catarrhalis; Neutrophils; Rats; Rats, Sprague-Dawley; Streptococcus | 2012 |
Colistin stimulates the activity of neutrophil elastase and Pseudomonas aeruginosa elastase.
Topics: Adolescent; Adult; alpha 1-Antitrypsin; Amino Acid Chloromethyl Ketones; Anti-Bacterial Agents; Anticoagulants; Bacterial Proteins; Ceftazidime; Child; Colistin; Cystic Fibrosis; Enzyme Activation; Erythromycin; Female; Gentamicins; Heparin; Humans; In Vitro Techniques; Leukocyte Elastase; Male; Metalloendopeptidases; Respiratory Tract Infections; Serine Proteinase Inhibitors; Sputum; Tobramycin | 2002 |
Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Cystic Fibrosis; DNA, Bacterial; Drug Resistance; Erythromycin; Genes, Bacterial; Humans; Membrane Transport Proteins; Methyltransferases; Microbial Sensitivity Tests; Mutation; Oligonucleotide Probes; Reverse Transcriptase Polymerase Chain Reaction; Ribosomes; Staphylococcal Infections; Staphylococcus aureus | 2002 |
N.A.C. AND ANTIBIOTICS IN CYSTIC FIBROSIS.
Topics: Acetylcysteine; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Cysteine; Cystic Fibrosis; Erythromycin; Fusidic Acid; Humans; Penicillins; Pharmacology; Protein Synthesis Inhibitors; Tetracycline | 1965 |
SERUM TRANSAMINASE ACTIVITY IN CHRONICALLY ILL CHILDREN ON ERYTHROMYCIN PROPHYLAXIS.
Topics: Adolescent; Aspartate Aminotransferases; Blood Chemical Analysis; Child; Chronic Disease; Cystic Fibrosis; Erythromycin; Humans | 1965 |
LIPID PATTERNS OF ANTIBIOTIC RESISTANT AND SENSITIVE STRAINS OF STAPHYLOCOCCUS AUREUS ASSOCIATED WITH CYSTIC FIBROSIS OF THE PANCREAS.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Chloramphenicol; Chromatography; Cystic Fibrosis; Drug Resistance, Microbial; Erythromycin; Fatty Acids; Humans; Kanamycin; Lipid Metabolism; Lipids; Neomycin; Penicillin Resistance; Sputum; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus Phages; Tetracycline | 1965 |
[Legionnaires' disease in cystic fibrosis].
Topics: Antibodies, Bacterial; Child, Preschool; Cystic Fibrosis; Diagnosis, Differential; Erythromycin; Humans; Legionella; Legionnaires' Disease; Male | 1984 |
[A case of cystic fibrosis in a Japanese student].
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cystic Fibrosis; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Japan; Male; Pseudomonas Infections; Quinolones; Respiratory Tract Infections | 1995 |
The effect of erythromycin on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum.
Topics: Anti-Bacterial Agents; Bronchiectasis; Cystic Fibrosis; Elasticity; Erythromycin; Humans; Mucociliary Clearance; Rheology; Sputum; Viscosity | 2001 |
[Refractory infection with Pseudomonas aeruginosa and the trend of clinical studies].
Topics: Adult; Bacterial Outer Membrane Proteins; Bronchiolitis; Cystic Fibrosis; Erythromycin; Exotoxins; Humans; Male; Pancreatic Elastase; Pseudomonas aeruginosa; Pseudomonas Infections; Serine Endopeptidases | 1991 |
Inhibition of Pseudomonas aeruginosa by ascorbic acid acting singly and in combination with antimicrobials: in-vitro and in-vivo studies.
Topics: Adolescent; Animals; Anti-Bacterial Agents; Ascorbic Acid; Child; Cystic Fibrosis; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Humans; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulfamethoxazole; Trimethoprim | 1974 |
Discoloration of the teeth in a 24-year-old patient with cystic fibrosis of the pancreas not primarily associated with tetracycline therapy. Report of a case.
Topics: Adult; Bronchopneumonia; Chloramphenicol; Cystic Fibrosis; Erythromycin; Female; Humans; Kanamycin; Penicillins; Polymyxins; Streptomycin; Tetracycline; Tooth Discoloration | 1967 |
Sensitivity of Pseudomonas aeruginosa to normal serum and to polymyxin.
Topics: Animals; Blood; Blood Bactericidal Activity; Chloramphenicol; Chlortetracycline; Cystic Fibrosis; Dactinomycin; Detergents; Erythromycin; Guinea Pigs; Humans; Immune Sera; Kanamycin; Mitomycins; Penicillins; Polymyxins; Pseudomonas; Pseudomonas aeruginosa; Temperature | 1969 |
Evolution of plasmids in vivo in a strain of Staphylococcus aureus.
Topics: Clindamycin; Cystic Fibrosis; Erythromycin; Extrachromosomal Inheritance; Fusidic Acid; Genetics, Microbial; Humans; Lincomycin; Mutation; Penicillin Resistance; Penicillinase; Penicillins; Staphylococcus | 1974 |
In vivo penetration of antibiotics into sputum in cystic fibrosis.
Topics: Acetylcysteine; Aerosols; Ampicillin; Anti-Bacterial Agents; Biological Assay; Cephaloridine; Cloxacillin; Cystic Fibrosis; Erythromycin; Gentamicins; Humans; Infection Control; Lincomycin; Methicillin; Molecular Weight; Novobiocin; Sputum; Sulfonamides | 1968 |
Absorption of antibiotics in cystic fibrosis.
Topics: Child; Cloxacillin; Cystic Fibrosis; Erythromycin; Humans; Intestinal Absorption; Protein Binding | 1970 |
Serum unbound levels of cloxacillin and erythromycin in cystic fibrosis.
Topics: Adolescent; Child; Child, Preschool; Cloxacillin; Cystic Fibrosis; Erythromycin; Humans; Infant; Protein Binding; Respiratory System; Staphylococcal Infections; Staphylococcus | 1970 |